Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-31 @ 10:51 PM
Study NCT ID:
NCT01526928
Status:
TERMINATED
Last Update Posted:
2020-08-04
First Post:
2012-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients
Sponsor:
Clovis Oncology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-31
First Submit QC Date:
None
Study First Post Date:
2012-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-11
Results First Submit QC Date:
None
Results First Post Date:
2020-01-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-26
Last Update Post Date:
2020-08-04
Last Update Post Date Type:
ACTUAL